proqolid

Home > Instruments > Parkinson's Disease Sleep Scale (PDSS)

Parkinson's Disease Sleep Scale (PDSS)

 
Developed in 2001. Originally termed the King's Max-Planck (KMP) Scale
The PDSS was later extended to a frequency measure scale: the PDSS-2
 

Author(s)

 

Purpose

  • Pathology:

Nervous system diseases

  • Disease:

Parkinson disease

  • Objective:

To quantify the various aspects of nocturnal sleep problems in Parkinson's disease

  • Population for intended use:

Adult

Caregivers

 
 

Characteristics

  • Type of instrument:

Signs and symptoms

  • Administration mode:

Caregiver-administered

Self-administered

  • Number of items:

15

  • Recall/Observation period:

In the past week

 
 

Language(s)

  • Original language:

English for the UK

  • List of existing translations:

The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.

PDSS

Afrikaans* English for Canada* German for Germany* Russian for Russia*
Bulgarian* English for South Africa* Hungarian* Spanish for Spain*
Chinese Finnish for Finland* Italian for Italy* Ukrainian*
Czech* French for Belgium* Japanese for Japan
Dutch for Belgium (Flemish)* French for Canada* Polish for Poland*
Dutch for the Netherlands* French for France* Romanian*

* Performed by the MAPI Institute

 

Bibliographic reference(s) of the original questionnaire

Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35 (Available for registered users on the Journal of Neurology, Neurosurgery, and Psychiatry's website)


Chaudhuri KR, Pal S, Bridgman K, Trenkwalder C. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability. Eur Neurol. 2001;46 Suppl 1:3-10

Chaudhuri KR, Pal S, Trenkwalder C, Bridgman K, Schueler P, Agapito C. Development of a novel scale for assessment of nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70:281

Last update: April 2012

Last update in collaboration with the author: March 2008